Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (191-200 of 350) with videos related to

Pageof 35
Sort By:
Leukemia & Lymphoma|August 26, 1998
Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferationA Ferrajoli, M Talpaz, R Kurzrock, et al.
Cancer|March 1, 1996
Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: implications for the treatment of patients with metastatic melanomaO Eton, M Talpaz, K H Lee, et al.
Investigational New Drugs|February 1, 1991
A phase I trial of recombinant alpha-2a interferon (Roferon-A) with weekly cisplatinumK Dhingra, M Talpaz, H M Dhingra, et al.
Cancer|May 15, 1987
The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemiaR Dekmezian, H M Kantarjian, M J Keating, et al.
Journal of Interferon Research|October 1, 1992
Identification of a complex formed between nuclear proteins and the transcriptional enhancer of interferon-inducible genes that is present in the peripheral blood myeloid cells of CML but not normal individualsD C Seong, K Gottlieb, S P Suh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemiaJ Rodriguez, J Cortes, M Talpaz, et al.
British Journal of Haematology|December 3, 1999
Chronic myelogenous leukaemia with p185(BCR/ABL) expression: characteristics and clinical significanceF Ravandi, J Cortes, M Albitar, et al.
Cancer Research|March 1, 1992
Interferon-stimulated genes in interferon-sensitive and -resistant chronic myelogenous leukemia patientsM Talpaz, Y Chernajovsky, K Troutman-Worden, et al.
Blood|August 1, 1988
Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemiaM Shtalrid, M Talpaz, R Kurzrock, et al.
Blood|January 15, 1991
Hybridization protection assay: a rapid, sensitive, and specific method for detection of Philadelphia chromosome-positive leukemiasK Dhingra, M Talpaz, M G Riggs, et al.
Pageof 35

Showing results (191-200 of 350) with videos related to

Sort By:
Pageof 35
Leukemia & Lymphoma|August 26, 1998
Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferationA Ferrajoli, M Talpaz, R Kurzrock, et al.
Cancer|March 1, 1996
Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: implications for the treatment of patients with metastatic melanomaO Eton, M Talpaz, K H Lee, et al.
Investigational New Drugs|February 1, 1991
A phase I trial of recombinant alpha-2a interferon (Roferon-A) with weekly cisplatinumK Dhingra, M Talpaz, H M Dhingra, et al.
Cancer|May 15, 1987
The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemiaR Dekmezian, H M Kantarjian, M J Keating, et al.
Journal of Interferon Research|October 1, 1992
Identification of a complex formed between nuclear proteins and the transcriptional enhancer of interferon-inducible genes that is present in the peripheral blood myeloid cells of CML but not normal individualsD C Seong, K Gottlieb, S P Suh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemiaJ Rodriguez, J Cortes, M Talpaz, et al.
British Journal of Haematology|December 3, 1999
Chronic myelogenous leukaemia with p185(BCR/ABL) expression: characteristics and clinical significanceF Ravandi, J Cortes, M Albitar, et al.
Cancer Research|March 1, 1992
Interferon-stimulated genes in interferon-sensitive and -resistant chronic myelogenous leukemia patientsM Talpaz, Y Chernajovsky, K Troutman-Worden, et al.
Blood|August 1, 1988
Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemiaM Shtalrid, M Talpaz, R Kurzrock, et al.
Blood|January 15, 1991
Hybridization protection assay: a rapid, sensitive, and specific method for detection of Philadelphia chromosome-positive leukemiasK Dhingra, M Talpaz, M G Riggs, et al.
Pageof 35